Cliniques universitaires Saint-Luc at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Cliniques universitaires Saint-Luc takes part in 4 sessions at ESMO 2026 in Madrid. Its program centres on advanced prostate cancer, from first treatment choice in hormone-sensitive disease to real-world care in castration-resistant disease. Other sessions cover surgery in HPV-related head and neck cancer and circulating tumour DNA analysis in locally advanced head and neck squamous cell carcinoma.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
University hospital of UCLouvain in Brussels, Belgium.
Talk
Sat Oct 24
08:30–08:50
The role of surgery
Challenges in the treatment approach of HPV-related head and neck cancers
Sarcoma, CNS, head & neck and rare cancers
Satellite
Sun Oct 25
13:10–13:40
Addressing myths in first treatment choice to optimise outcomes and patient wellbeing in mHSPC
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer · with Gustave Roussy
Genitourinary cancers
Satellite
Sun Oct 25
13:40–13:45
Audience Q&A: Advanced prostate cancer
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer · with Hospital Clínico San Carlos, Gustave Roussy
Genitourinary cancers
Satellite
Sun Oct 25
18:30–18:35
Welcome & Introduction
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions
Genitourinary cancers
Satellite
Sun Oct 25
18:45–18:55
Establishing the Routes Our Patients Have Travelled: A Review of Real-World Evidence
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions
Genitourinary cancers
Satellite
Sun Oct 25
19:10–19:30
Placing Data into Practice: What Constitutes Contemporary Best Practice Approaches Upon Progression to mCRPC?
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions · with Europa Uomo, Oncology Institute of Southern Switzerland (IOSI)
Genitourinary cancers
Satellite
Sun Oct 25
19:30–19:45
Partnering With Our Patients Across Their mCRPC Journey: Considerations Beyond Initial Treatment Selection
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions · with Europa Uomo, Oncology Institute of Southern Switzerland (IOSI)
Genitourinary cancers
Satellite
Sun Oct 25
19:45–19:55
Questions and Answers Session: Expert Insights for Your Compelling Questions
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions · with Europa Uomo, Oncology Institute of Southern Switzerland (IOSI)
Genitourinary cancers
Satellite
Sun Oct 25
19:55–20:00
Final Remarks and Closing
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions
Genitourinary cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Cliniques universitaires Saint-Luc

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction